|
Gregory Sieczkiewicz, Ph.D.
Associate
Boston
Dr. Gregory Sieczkiewicz has core strengths in the fields of molecular biology, functional genomics, proteomics, metabolomics, cellular and developmental biology, immunology, biochemistry, bacteriology, neurobiology, enzymology, and medical devices. Greg focuses his practice on patent preparation and prosecution, and has handled litigation matters in the medical device, pharmaceutical, and antibody diagnostics areas. Greg is also often involved in licensing transactions and due-diligence analyses of intellectual property assets. Greg has represented both start-up and established companies, as well as non-profit research and educational institutions, hospitals, and venture capital firms. Greg has been a registered patent attorney, and previously a registered patent agent, in private practice in the Boston intellectual property community for more than seven years.
Greg's doctoral research at Tufts University School of Medicine focused on the identification and characterization of genetic regulators of blood vessel proliferation and motility. Greg was a post-doctoral fellow at the National Cancer Institute, where he studied the role of calcium signaling in tumor-induced angiogenesis.
Bars and Court Admissions
Massachusetts
Rhode Island
U.S. Patent & Trademark Office (Agency)
professional / civic involvement
Boston Patent Law Association, Member of the Board of Governors and Co-Chair of Ethics & Grievances Committee
Massachusetts Bar Association, Member
American Intellectual Property Law Association, Member
Alumni Recruiter, College of the Holy Cross
publications
Legal
Solomon, LM and GJ Sieczkiewicz. "Impact of the US Patent System on the Promise of Personalized Medicine," Gender Med. (2007) 4(3):187-192.
Scientific
Moody TW, Chiles J, Moody E, Sieczkiewicz GJ, and Kohn EC. "CAI inhibits the growth of small cell lung cancer cells," Lung Cancer (2003) 39(3):279-88.
Sieczkiewicz GJ and IM Herman. "TGF-beta 1 signaling controls retinal pericyte contractile protein expression," Microvasc. Res. (2003) 66:190-6.
Sieczkiewicz GJ, Hussain M, and Kohn EC. "Angiogenesis and metastasis," Cancer Treat. Res. (2002) 107:353-81.
Inventor, U.S. Patent No. 6,521,420 "Hypertension associated transcription factors and uses therefore", issued February 18, 2003.
| 